A Pilot Trial of Rituxan in Refractory Myasthenia Gravis
NCT00619671
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Refractory Myasthenia Gravis
Interventions
DRUG:
Rituximab (Rituxan)
Sponsor
University of Vermont
Collaborators
[object Object]